Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
Oral Surgery, Oral Medicine, and Oral Pathology
|
February 1, 1986
Oral complications of multimodality therapy for advanced squamous cell carcinoma of head and neck
D Archibald, P B Lockhart, S T Sonis, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
December 5, 2021
Developmental age and biological sex influence muscarinic receptor function and neuron morphology within layer VI of the medial prefrontal cortex
Ashutosh V Patel, Sierra A Codeluppi, Kelsy S J Ervin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1985
Alkylating agent resistance: in vitro studies with human cell lines
E Frei, C A Cucchi, A Rosowsky, et al.
The American Journal of Pathology
|
February 23, 1999
Specific regional transcription of apolipoprotein E in human brain neurons
P T Xu, J R Gilbert, H L Qiu, et al.
The Laryngoscope
|
March 1, 1986
Pathology of surgery after induction chemotherapy: an analysis of resectability and locoregional control
C M Norris, J R Clark, E Frei, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1984
Development of methotrexate resistance in a human squamous cell carcinoma of the head and neck in culture
E Frei, A Rosowsky, J E Wright, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
A phase I trial of combination therapy with continuous-infusion PALA and continuous-infusion 5-FU
G R Weiss, T J Ervin, M W Meshad, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 10, 2000
The influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: secondary analysis of RTOG 85-03
A Aref, B A Berkey, J G Schwade, et al.
Clinical Colorectal Cancer
|
July 2, 2013
Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal cancer
Johanna C Bendell, Thomas J Ervin, David Gallinson, et al.
Molecular and Cellular Biology
|
December 15, 2025
Deletion of Adaptor Protein ShcD Impairs Olfactory Bulb Morphology and Function
Hannah N Robeson, Laura A New, Begüm Alural, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
Oral Surgery, Oral Medicine, and Oral Pathology
|
February 1, 1986
Oral complications of multimodality therapy for advanced squamous cell carcinoma of head and neck
D Archibald, P B Lockhart, S T Sonis, et al.
Cerebral Cortex (New York, N.Y. : 1991)
|
December 5, 2021
Developmental age and biological sex influence muscarinic receptor function and neuron morphology within layer VI of the medial prefrontal cortex
Ashutosh V Patel, Sierra A Codeluppi, Kelsy S J Ervin, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1985
Alkylating agent resistance: in vitro studies with human cell lines
E Frei, C A Cucchi, A Rosowsky, et al.
The American Journal of Pathology
|
February 23, 1999
Specific regional transcription of apolipoprotein E in human brain neurons
P T Xu, J R Gilbert, H L Qiu, et al.
The Laryngoscope
|
March 1, 1986
Pathology of surgery after induction chemotherapy: an analysis of resectability and locoregional control
C M Norris, J R Clark, E Frei, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 1, 1984
Development of methotrexate resistance in a human squamous cell carcinoma of the head and neck in culture
E Frei, A Rosowsky, J E Wright, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
A phase I trial of combination therapy with continuous-infusion PALA and continuous-infusion 5-FU
G R Weiss, T J Ervin, M W Meshad, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 10, 2000
The influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: secondary analysis of RTOG 85-03
A Aref, B A Berkey, J G Schwade, et al.
Clinical Colorectal Cancer
|
July 2, 2013
Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal cancer
Johanna C Bendell, Thomas J Ervin, David Gallinson, et al.
Molecular and Cellular Biology
|
December 15, 2025
Deletion of Adaptor Protein ShcD Impairs Olfactory Bulb Morphology and Function
Hannah N Robeson, Laura A New, Begüm Alural, et al.
Page
of 9